Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Research finding could offer new way to fight deadly pancreatic cancer

Pancreatic cancer, most frequently pancreatic ductal adenocarcinoma (PDAC), is the most lethal and aggressive of all cancers. Unfortunately, there are not many effective therapies available other than surgery, and that is not an option for many patients.

10 Apr 2017

MIT engineers develop more sensitive approach to reveal ovarian tumors

Most ovarian cancer is diagnosed at such late stages that patients' survival rates are poor. However, if the cancer is detected earlier, five-year survival rates can be greater than 90 percent.

10 Apr 2017

Genomic Analysis Technologies: Past, Present and Future

In this interview, Jay Flatley, Executive Chairman of Illumina, gives an introduction to Illumina and the next generation genomics tools they provide.

From Pittcon 10 Apr 2017

Tumor microenvironment poses unique challenges for effective ovarian cancer T-cell therapy

Fred Hutchinson Cancer Research Center immunotherapy researchers Drs. Kristin Anderson and Philip Greenberg and their colleagues are working on ways to tweak their team's early successes with T-cell therapy for leukemia to apply to solid tumors.

5 Apr 2017

Stanford-led researchers use microbubbles and ultrasound to detect malignant cancers

A team led by researchers from the Stanford University School of Medicine has demonstrated a way to diagnose cancer without resorting to surgery, raising the possibility of far fewer biopsies.

5 Apr 2017

Researchers identify biomarker for likely aggressive, early-stage breast cancers

The one-size-fits-all approach to early stage breast cancer creates a paradox: Millions of dollars are spent on unnecessary surgeries and radiation to treat women with low-risk 'in situ' lesions, an estimated 85% of which would never progress to invasive cancers.

4 Apr 2017

New imaging test can show key enzyme in ovarian cancer to help guide treatment choices

A new imaging test may provide the ability to identify ovarian cancer patients who are candidates for an emerging treatment that targets a key enzyme cancer cells need to survive.

3 Apr 2017

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Novocure announced today results from its phase 2 pilot INNOVATE trial studying Tumor Treating Fields (TTFields) in combination with weekly paclitaxel for the treatment of recurrent ovarian cancer.

31 Mar 2017

Researchers explore factors that influence patient's intent to get colorectal cancer screening

A patient's confidence in their ability to schedule, plan for and properly conduct their part in colorectal screening methods is a key factor that predicts whether they intend to be tested, according to new research from Penn State College of Medicine. The findings suggest that educating patients could improve screening rates.

30 Mar 2017

FDA approves new maintenance therapy for recurrent cancers

The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.

27 Mar 2017

Increase in BRCA testing may not necessarily mean better diagnosis of women at risk, study suggests

More women are requesting BRCA gene testing associated with certain types of cancer thanks to increased interest in the procedure.

25 Mar 2017

Study finds steady increase in BRCA testing among low-risk women

Discovery of the BRCA genetic mutation in the mid-90s represented a breakthrough in breast and ovarian cancer prevention. About 5-10% of breast cancer cases and 10-18% of ovarian cancer cases can be attributed to two BRCA mutations.

23 Mar 2017

Researchers develop new method that uses gene editing to find cancer's weak spots

Genetic mutations that cause cancer also weaken cancer cells, creating an opportunity for researchers to develop drugs that will selectively kill them, while sparing normal cells.

20 Mar 2017

Studies question use of readmission rate as metric in surgeries for ovarian cancer patients

To reduce costs and improve quality of care, the Centers for Medicaid and Medicare Services has made reducing readmission rates a priority, yet research studies presented today at the Society of Gynecologic Oncology’s 2017 Annual Meeting for Women’s Cancer question the use of the metric in surgeries performed in patients with ovarian cancer.

13 Mar 2017

Researchers identify protein biomarker linked to prognosis in high-grade serous ovarian cancer

Ovarian cancer researchers have identified a protein biomarker expressed on the surface of tumour cells in high-grade serous ovarian cancer, the most common and lethal subtype of the disease.

7 Mar 2017

Clinical study seeks to examine new combination therapy for treating AML patients

A pair of drugs that may be a one-two punch needed to help combat acute myeloid leukemia (AML), an aggressive blood cancer that kills nearly three-fourths of patients within five years of diagnosis, is the focus of a new multi-center clinical trial that will enroll patients at three sites across the U.S.

7 Mar 2017

Michigan Medicine opens first clinic in the United States that focuses on prostate cancer risk

It's well known that women with certain hereditary genetic mutations, particularly BRCA1 and BRCA2, have an increased risk of breast cancer. But in recent years, researchers have discovered a link between some of those same genetic mutations - along with a handful of others - and aggressive prostate cancer.

3 Mar 2017

Blocking protein found on surface of ovarian cancer cells could prevent metastasis, research suggests

Blocking a protein found on the surface of ovarian cancer cells could prevent or reduce the spread of the disease to other organs, according to new research at the University of Illinois at Chicago.

3 Mar 2017

NR could potentially prevent chemotherapy-induced peripheral neuropathy in cancer patients

A new study in rats suggests that nicotinamide riboside (NR), a form of vitamin B3, may be useful for treating or preventing nerve pain (neuropathy) caused by chemotherapy drugs.

24 Feb 2017

Study: Hormonal maintenance therapy may improve survival in women with low-grade serous carcinoma

For women with a rare subtype of epithelial ovarian or peritoneum cancer, known as low-grade serous carcinoma, hormone maintenance therapy may significantly improve survival, according to a new study from researchers at The University of Texas MD Anderson Cancer Center.

22 Feb 2017

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Research finding could offer new way to fight deadly pancreatic cancer

MIT engineers develop more sensitive approach to reveal ovarian tumors

Genomic Analysis Technologies: Past, Present and Future

Tumor microenvironment poses unique challenges for effective ovarian cancer T-cell therapy

Stanford-led researchers use microbubbles and ultrasound to detect malignant cancers

Researchers identify biomarker for likely aggressive, early-stage breast cancers

New imaging test can show key enzyme in ovarian cancer to help guide treatment choices

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Researchers explore factors that influence patient's intent to get colorectal cancer screening

FDA approves new maintenance therapy for recurrent cancers

Increase in BRCA testing may not necessarily mean better diagnosis of women at risk, study suggests

Study finds steady increase in BRCA testing among low-risk women

Researchers develop new method that uses gene editing to find cancer's weak spots

Studies question use of readmission rate as metric in surgeries for ovarian cancer patients

Researchers identify protein biomarker linked to prognosis in high-grade serous ovarian cancer

Clinical study seeks to examine new combination therapy for treating AML patients

Michigan Medicine opens first clinic in the United States that focuses on prostate cancer risk

Blocking protein found on surface of ovarian cancer cells could prevent metastasis, research suggests

NR could potentially prevent chemotherapy-induced peripheral neuropathy in cancer patients

Study: Hormonal maintenance therapy may improve survival in women with low-grade serous carcinoma

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in